Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Posts Up-Ticks in Q1 Revenue, R&D, and Loss

NEW YORK, May 1 - Lexicon Genetics today reported an up-tick in first-quarter amid increased R&D spending and widening net losses.

 

Total revenue for the period ended March 31 inched up to $8.1 million from $7.7 million year over year. Lexicon said receipts from collaborative research, which jumped to $5.0 million in the first quarter 2003 from $4.3 million year in the same period last year, drove the revenue. Income from subscription and license fees in the quarter, however, fell to $3.1 million from $3.4 million.

 

R&D spending in the first quarter increased to $19.8 million from $16.9 million in the first quarter last year, Lexicon said. Included in the R&D numbers was $1.3 million in stock-based compensation in both periods.

 

Net loss for the quarter swelled to $17.1 million, or $.33 per share, from $14 million, or $.27 per share, for the same time last year, Lexicon said.

 

The company had around $107.6 million in cash and investments as of March 31.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.